IBER.WS
Ibere Pharmaceuticals Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share
IBER.WS
IBER.WS
Delisted
IBER.WS was delisted on the 15th of February, 2023.
1 hedge funds and large institutions have $108K invested in Ibere Pharmaceuticals Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share in 2023 Q1 according to their latest regulatory filings, with funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 32 closing their positions.
New
Increased
Maintained
Reduced
Closed
less capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
Holders
1
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
No buyers this quarter
Top Sellers
| 1 | -$1.51M | |
| 2 | -$207K | |
| 3 | -$16K | |
| 4 |
CAC
Cowen and Company
New York
|
-$4.47K |
| 5 |
PC
Periscope Capital
Toronto,
Ontario, Canada
|
-$4.06K |